Vela Diagnostics' ViroKey SARS-CoV-2 RT-PCR Test Receives the US FDA's Emergency Use Authorization
Shots:
- The US FDA has granted EUA to the Vela’s PCR test that detects SARS-CoV-2 n nasopharyngeal and oropharyngeal swabs
- The manual version of the ViroKey enables flexible sample processing and quick adoption of the test by laboratories with existing ABI 7500 Fast Dx instruments but for high throughput testing- an automated version of the assay is used for the optimization of a workflow consisting of the Sentosa SX101 instrument- in conjunction with ABI 7500 Fast Dx PCR instrument or the Sentosa SA201 instrument
- ViroKey SARS-CoV-2 RT-PCR Test has also received the CE mark and provisional approval from the Singapore Health Sciences Authority
Ref: Vela Diagnostic | Image: Biospectrum Asia
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com